Study: Cancer patients twice as likely to die from COVID-19 | Inquirer Technology

Study: Cancer patients twice as likely to die from COVID-19

/ 06:37 AM May 29, 2020

WASHINGTON — People with cancer are more than twice as likely to die from COVID-19 than those without it, a large study published Thursday found.

The data on more than 900 patients in the US, Canada, and Spain that appeared in a paper in The Lancet found that mortality increased the further cancer had progressed.

Cancer patients with decreased ability to carry out daily life tasks were more at risk than those with higher functionality.

ADVERTISEMENT

The paper’s authors looked at how many people died within 30 days of being diagnosed with COVID-19 of all causes.

FEATURED STORIES

“The 30-day all-cause mortality was 13 percent, more than twice the mortality reported as the global average by Johns Hopkins,” Toni Choueiri, an oncologist at the Dana-Farber Cancer Institute who co-authored the paper told AFP.

In keeping with previous studies, the team also found that advanced age, male sex, the presence of two or more underlying conditions, and former smoking status were all also tied to increased risk of death.

But the receipt of chemotherapy or other anti-cancer therapies within four weeks of COVID-19 diagnosis did not affect mortality outcomes.

“Taken together, these results suggest that fit patients with cancer and few comorbidities can and should proceed with appropriate anti-cancer treatment,” said Choueiri.

But those who have poor daily life functionality or a cancer which is progressing “need to have thoughtful conversations with their oncology providers about risk versus benefit of anti-cancer treatment,” he added.

Bill Cance, chief medical and scientific officer for the American Cancer Society which provided funding for the study, said: “This is a very high impact paper that shows how cancer patients are at higher risk for Covid.”

ADVERTISEMENT

He added that the paper suggested that the drug combination of hydroxychloroquine and azithromycin may cause a three-fold greater risk of death an area that needed further exploration.

The authors of the paper themselves said they could not draw a conclusion on this trend because it may have arisen from other factors.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TOPICS: 2019-nCoV, Cancer, China, coronavirus, COVID-19, Health, International news, nCoV, NCOV update, News, novel coronavirus, outbreak, pandemic, Virus, World, World News, Wuhan
TAGS: 2019-nCoV, Cancer, China, coronavirus, COVID-19, Health, International news, nCoV, NCOV update, News, novel coronavirus, outbreak, pandemic, Virus, World, World News, Wuhan

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.